Report cover image

U.S. optic neuritis Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published Oct 01, 2022
Length 122 Pages
SKU # DAABD17480608

Description

U.S. optic neuritis Market - Industry Trends and Forecast to 2029

U.S. Optic Neuritis Market is projected to register a CAGR of 5.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

U.S. Optic Neuritis Market, By Treatment (Corticosteroids, IV Immunoglobulin, Supplements, and Others), By Diagnosis (MRI Scan, Blood Tests, Occular Cohernce Tomography, Lumbar Puncture, and Others), By Route of Administration (Oral, Parenteral, and Others), By End User (Hospitals, Clinics, Academic Research Institutes, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the United States Optic Neuritis Market are:
• The rising healthcare expenditure and strategic initiatives by market players are giving opportunities to the Optic Neuritis market to enhance the treatments.
• An increase in the reprocessing of methodological advancements is enhancing the growth of the Optic Neuritis market.

Market Players

Some of the key market players for the United States Optic Neuritis Market are listed below:
• Pfizer Inc.
• Novartis AG
• Boehringer Ingelheim International GmbH
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Bristol-Myers Squibb Company
• Fresenius Kabi USA
• ABBVIE
• Hikma
• Merck & Co.
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals LLC.
• AdvaCare Pharma
• GSK plc
• Akorn Operating Company LLC
• Jubilant Cadista Pharmaceuticals Inc.
• Novitium Pharma
• OthersCompanies

• Pfizer Inc.
• Novartis AG
• Boehringer Ingelheim International GmbH
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Bristol-Myers Squibb Company
• Fresenius Kabi USA
• ABBVIE
• Hikma
• Merck & Co.
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals LLC.
• AdvaCare Pharma
• GSK plc
• Akorn Operating Company LLC
• Jubilant Cadista Pharmaceuticals Inc.
• Novitium Pharma
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

122 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of U.S. Optic Neuritis Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Treatment Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel
4.2 Porter's Five Forces Model
5 Epidemiology
6 Industry Insights
6.1 Patent Analysis
6.2 Drug Treatment Rate By Matured Markets
6.3 Demographic Trends: Impacts On All Incidence Rates
6.4 Patient Flow Diagram
6.5 Key Pricing Strategies
6.6 Key Patient Enrollment Strategies
7 Pipeline Analysis
8 U.S. Optic Neuritis Market: Regulations
8.1 Regulation In The U.S.:
9 Market Overview
9.1 Drivers
9.1.1 Rising Prevalence Of Eye Disorders
9.1.2 Increase In Aging Population
9.1.3 Rise In Traumatic Injuries
9.2 Restraints
9.2.1 High Cost Associated With Optic Nerve Disorders Treatment
9.2.2 Risks Associated With Various Treatments Methods
9.3 Opportunities
9.3.1 Rise In Healthcare Expenditure
9.3.2 Strategic Initiatives Of Key Players
9.4 Challenges
9.4.1 Negative Effects Of Systemic Steroids
9.4.2 Lack Of Awareness Among People Regarding Different Eye Treatments
10 U.S. Optic Neuritis Market, By Treatment
10.1 Overview
10.2 Corticosteroids
10.2.1 Methylprednisolone
10.2.2 Prednisone
10.2.3 Others
10.3 Iv Immunoglobulin
10.4 Supplements
10.5 Others
11 U.S. Optic Neuritis Market, By Diagnosis
11.1 Overview
11.2 Mri Scan
11.3 Blood Test
11.4 Ocular Coherence Tomography
11.5 Lumbar Puncture
11.6 Others
12 U.S. Optic Neuritis Market, By Route Of Administration
12.1 Overview
12.2 Parenteral
12.3 Oral
13 U.S. Optic Neuritis Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Clinics
13.4 Academic And Research Institutes
13.5 Others
14 U.S. Optic Neuritis Market, By Distribution Channel
14.1 Overview
14.2 Hospital Pharmacy
14.3 Retail Pharmacy
14.4 Others
15 U.S. Optic Neuritis Market: Company Landscape
15.1 Company Share Analysis: United States
16 Swot Analysis
17 Company Profile
17.1 Pfizer Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Product Portfolio
17.1.4 Recent Development
17.2 Novartis Ag
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Product Portfolio
17.2.4 Recent Development
17.3 Boehringer Ingelheim International Gmbh.
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Product Portfolio
17.3.4 Recent Development
17.4 Viatris Inc.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Product Portfolio
17.4.4 Recent Development
17.5 Bausch & Lomb Incorporated
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Product Portfolio
17.5.4 Recent Developments
17.6 Bristol – Myers Squibb Company
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Fresenius Kabi Usa
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Abbvie Inc.
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Advacarepharma
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Akorn Operating Company Llc.
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.11 Amneal Pharmaceuticals Llc
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Gsk Plc
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Development
17.13 Hikma Pharmaceuticals Plc
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Product Portfolio
17.13.4 Recent Development
17.14 Jubilant Cadista
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Merck & Co., Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Developments
17.16 Novitium Pharma
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
17.17 Teva Pharmaceutical Industries Ltd.
17.17.1 Company Snapshot
17.17.2 Revenue Analysis
17.17.3 Product Portfolio
17.17.4 Recent Development
17.18 Accure Therepeutics
17.18.1 Company Snapshot
17.18.2 Product Portfolio
17.18.3 Recent Development
17.19 Acorda Therapeutics Inc.
17.19.1 Company Snapshot
17.19.2 Revenue Analysis
17.19.3 Product Portfolio
17.19.4 Recent Development
17.20 Biogen Inc.
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Development
17.21 Mallinckrdot Pharmaceuticals
17.21.1 Company Snapshot
17.21.2 Revenue Analysis
17.21.3 Product Portfolio
17.21.4 Recent Development
17.22 Noveome Biotherapeutics, Inc.
17.22.1 Company Snapshot
17.22.2 Product Portfolio
17.22.3 Recent Development
17.23 Sanofi
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Product Portfolio
17.23.4 Recent Developments
18 Questionnaire
19 Related Reports 122
List Of Tables
Table 1 U.S. Optic Neuritis Market, Pipeline Analysis
Table 2 U.S. Optic Neuritis Market, By Treatment, 2020-2029 (Usd Million)
Table 3 U.S. Optic Neuritis Market, By Treatment, 2020-2029 (Volume In Million)
Table 4 U.S. Corticosteroids In Optic Neuritis Market, By Treatment, 2020-2029 (Usd Million)
Table 5 U.S. Optic Neuritis Market, By Diagnosis, 2020-2029 (Usd Million)
Table 6 U.S. Optic Neuritis Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 7 U.S. Optic Neuritis Market, By End User, 2020-2029 (Usd Million)
Table 8 U.S. Optic Neuritis Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures
Figure 1 U.S. Optic Neuritis Market: Segmentation
Figure 2 U.S. Optic Neuritis Market: Data Triangulation
Figure 3 U.S. Optic Neuritis Market: Droc Analysis
Figure 4 U.S. Optic Neuritis Market: Global Vs Regional Market Analysis
Figure 5 U.S. Optic Neuritis Market: Company Research Analysis
Figure 6 U.S. Optic Neuritis Market: Interview Demographics
Figure 7 U.S. Optic Neuritis Market: Dbmr Market Position Grid
Figure 8 U.S. Optic Neuritis Market: Market End User Coverage Grid
Figure 9 U.S. Optic Neuritis Market: Vendor Share Analysis
Figure 10 U.S. Optic Neuritis Market: Segmentation
Figure 11 The Increasing Prevalence Of Eye Disorders And Rise In The Geriatric Population Are Expected To Drive The U.S. Optic Neuritis Market In The Forecast Period Of 2022 To 2029
Figure 12 Corticosteroids Segment Is Expected To Account For The Largest Share Of The U.S. Optic Neuritis Market In 2022 And 2029
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The U.S. Optic Neuritis Market
Figure 14 U.S. Optic Neuritis Market: By Treatment, 2021
Figure 15 U.S. Optic Neuritis Market: By Treatment, 2022-2029 (Usd Million)
Figure 16 U.S. Optic Neuritis Market: By Treatment, Cagr (2022-2029)
Figure 17 U.S. Optic Neuritis Market: By Treatment, Lifeline Curve
Figure 18 U.S. Optic Neuritis Market: By Diagnosis, 2021
Figure 19 U.S. Optic Neuritis Market: By Diagnosis, 2022-2029 (Usd Million)
Figure 20 U.S. Optic Neuritis Market: By Diagnosis, Cagr (2022-2029)
Figure 21 U.S. Optic Neuritis Market: By Diagnosis, Lifeline Curve
Figure 22 U.S. Optic Neuritis Market: By Route Of Administration, 2021
Figure 23 U.S. Optic Neuritis Market: By Route Of Administration, 2022-2029 (Usd Million)
Figure 24 U.S. Optic Neuritis Market: By Route Of Administration, Cagr (2022-2029)
Figure 25 U.S. Optic Neuritis Market: By Route Of Administration, Lifeline Curve
Figure 26 U.S. Optic Neuritis Market: By End User, 2021
Figure 27 U.S. Optic Neuritis Market: By End User, 2022-2029 (Usd Million)
Figure 28 U.S. Optic Neuritis Market: By End User, Cagr (2022-2029)
Figure 29 U.S. Optic Neuritis Market: By End User, Lifeline Curve
Figure 30 U.S. Optic Neuritis Market: By Distribution Channel, 2021
Figure 31 U.S. Optic Neuritis Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 32 U.S. Optic Neuritis Market: By Distribution Channel, Cagr (2022-2029)
Figure 33 U.S. Optic Neuritis Market: By Distribution Channel, Lifeline Curve
Figure 34 U.S. Optic Neuritis Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us